Designs and develops high throughput mutagenesis technologies for studying functional genomics in mammalian systems. Lexicon went public in June 2000 (NASDAQ:LEXG).
Investors 1
Mentions in press and media 2
| Date | Title | Description |
| 08.10.2013 | Bay City Capital Names Ashley Ledbetter Dombkowski, PhD, Managing Director | San Francisco, CA — Bay City Capital, a leading venture capital firm focused on early-stage to growth equity investments in the life sciences, today announced Ashley Dombkowski, Ph.D. joined as Managing Director.
“Drug discovery and develo... |
| 13.05.2013 | Bay City Capital Expands Team with the Addition of David Beier, JD | San Francisco, CA — Bay City Capital, a leading venture capital firm focused on early-stage to growth equity investments in the life sciences, today announced the addition of David Beier, JD as Managing Director. David served as a senior of... |
Reviews 0
